Manager PR & Communications Jan Phillip Denkers
Mindpeak: Top 50 Digital Health Company 2024
Mindpeak GmbH, global innovator in AI-driven digital pathology, has been named to CB Insights’ prestigious Digital Health 50 list for 2024. This recognition highlights the ...
Read more …Grand opening of new altona Diagnostics production site
In the fall of 2024, altona celebrated the grand opening of its new extraction chemistry production site located at Schnackenburgallee in Hamburg opposite the premises ...
Read more …DFKI Laboratory Lübeck officially opened
Dirk Schrödter, Minister for Digitalization and Head of the State Chancellery of Schleswig-Holstein, today presented the funding decision for the new laboratory of the German ...
Read more …Hamburg clusters cooperate in unique KLIMAready project
1.5-degree target, climate neutrality and sustainable processes at all levels. What the world, and therefore also the Free and Hanseatic City of Hamburg, has set ...
Read more …HALRIC gathers 100 people in Hamburg
On 24-25 September over 100 people attended HALRIC’s conference at the Bahrenfeld Campus in Hamburg. The first day kicked off with a high-level panel session, ...
Read more …Richter BioLogics triples production capacity
Richter BioLogics GmbH & Co KG, the microbial biologics affiliate of Gedeon Richter Plc. celebrated the opening of ...
Read more …Indivumed: New Publication in Discover Oncology
Indivumed GmbH announced the fourth research publication enabled by the Indivumed Omics Hub. An interface for members of the Indivumed Global Clinical Network, the Omics ...
Read more …New management at altona Diagnostics in Argentina and Brazil
After more than six years at the helm of the Argentine and Brazilian subsidiaries of altona Diagnostics based in Buenos ...
Read more …Deeper Insights in Breast Cancer Metastasis
A collaborative effort between researchers from DESY, the University Medical Center Hamburg-Eppendorf (UKE), ...
Read more …SurgMark: FDA 510(k) Clearance for SchurSign Tissue Marker
In January SurgMark GmbH announced that the U.S. Food & Drug Administration (FDA) has issued a 510(k) premarket notification for ...
Read more …Synchron Acquires Equity Stake in ACQUANDAS
Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in patients with motor impairment, today announced the acquisition of an equity stake ...
Read more …"Stealth Effect"
An experiment led by a team of DESY and Universität Hamburg scientists has discovered that gold nanoparticles can move through liquid ...
Read more …